Micropump Market Recent Trends, Demand, Dynamic Innovation in Technology & Insights 2033 | FMI

 The global Micropump Market is predicted to register a CAGR of 18.4% over the forecast period, according to FMI’s analysis. The industry’s market value is anticipated to increase from US$ 2.4 billion in 2023 to US$ 12.8 billion by 2033 end.

The widespread application of micropumps due to their capability to effectively handle incredibly small portions of liquid is augmenting the market growth. Further, adding to the market growth is the fact that micropumps have gained wide recognition in the biomedical sector owing to their higher pumping flow rates and smaller dimensions. Additionally, the market is picking up momentum on account of surging demand for medical devices offering precise drug delivery.

The micropump market is favorably impacted by the increasing deployment of micropumps in microfluidic research. Moreover, the usage of micropumps also ensures an automated and smooth flow of medication periodically. To ensure accurate medication and avoid overdosing, micropumps are used by healthcare providers.

The surging popularity of drug delivery devices that use microelectromechanical technology (MEMS) due to their significant uses in the biomedical field, is propelling the market further. Additionally, the enhanced efforts to boost drug delivery efficiency in recent years have been augmenting market development.

Get Full Access @ https://www.futuremarketinsights.com/reports/micropump-market

Key Highlights:                                                                            

  • The United States is projected to be a significant micropump market in the predicted time. The market is expected to garner revenue of US$ 4.5 billion by 2033. The market is projected to demonstrate a CAGR of 2%.
  • China is projected to be the second leading market for micropump. The country holds a significant grip over the Asia Pacific micropump industry as it contributes substantially to regional growth. By 2033, the market is anticipated to reach US$ 5 million, expanding at a CAGR of 17.8%.
  • The United Kingdom is projected to attain US$ 538.7 million by 2033. A CAGR of 17.4% has been estimated for the United Kingdom in the upcoming years.
  • Japan is another significant market in the Asia Pacific region. The market is anticipated to achieve US$ 750.7 million by the year 2033. The market is expected to assume a CAGR of 16.8% from 2023 to 2033.
  • The in-vitro diagnostics segment is assessed to expand at a CAGR of 17.6% over the forecast period. Due to the extensive application of mechanical and non-mechanical pumps in in-vitro diagnostics, the segment is projected to assume a significant growth rate.

Latest News Containing Market Developments by Key Participants of Micropump Market:

  • In March 2022, Medtronic India introduced MiniMed 780G, a next-gen closed-loop insulin pump system. The system is designed for the treatment of type 1 diabetes in people ranging from 7 to 80 years of age. The MiniMed 780G allows customization of glucose goals with modifiable targets setting a minimum of 100 mg/dL.
  • In 2021, Bartels Mikrotechnik GmbH launched the mp-advance kit and an mp-select kit. The former kit includes an entire range of components to make up a complete microfluidic system. These components include mp6 micropumps, and electronics such as mp-Highdriver, mp-Lowdriver, mp-Highdriver4, and associated accessories. These micropumps transport a small number of liquids and gases and have rendered themselves indispensable in some sectors.

A Nano pump is a type of pump that is designed to move very small amounts of fluid, typically on the order of microliters or nanoliters. Micropumps are used in a variety of applications, including medical devices, chemical analysis, and microfluidic systems.

List Encompassing Key Players Operating in Micropump Industry

  • LEE Ventus
  • Sensile Medical
  • Cole-Parmer India Pvt Ltd
  • IDEX
  • Dolomite Microfluidics
  • The Lee Company
  • Gardner Denver
  • Takasago Electric, Inc.
  • Halma Plc
  • Servoflo Corporation

Market Segments Covered in Micropump Industry Analysis

By Product Type:

  • Mechanical Micropump
    • Piezoelectric Micropump
    • Peristaltic Micropump
    • Others
  • Non-mechanical Micropump

By Application:

  • Drug Delivery
  • In-vitro Diagnostics
  • Medical Devices
  • Others

By End User:

  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Diagnostic Centers
  • Academic & Research Institutes

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more